Protein biomarker discovery and validation: the long and uncertain path to clinical utility (Q36561644)

14 August 2017

1 reference

title

Protein biomarker discovery and validation: the long and uncertain path to clinical utility (English)

1 reference

14 August 2017

0 references

Nader Rifai

1 reference

14 August 2017

Michael A Gillette

series ordinal

1 reference

14 August 2017

Steven A Carr

series ordinal

1 reference

14 August 2017

publication date

1 August 2006

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

971-983

1 reference

DNA microarrays in breast cancer: the promise of personalised medicine

14 August 2017

cites work

1 reference

7 January 2021

Metabolite profiling: from diagnostics to systems biology

1 reference

7 January 2021

The case for early detection

1 reference

7 January 2021

The human plasma proteome: history, character, and diagnostic prospects

1 reference

7 January 2021

The US Food and Drug Administration perspective on cancer biomarker development

1 reference

7 January 2021

The roles of multiple proteomic platforms in a pipeline for new diagnostics

1 reference

7 January 2021

Serum protein markers for early detection of ovarian cancer

1 reference

7 January 2021

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide

1 reference

7 January 2021

Antibody arrays for high-throughput screening of antibody-antigen interactions

1 reference

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

7 January 2021

Multiplexed protein measurement: technologies and applications of protein and antibody arrays

1 reference

7 January 2021

Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.

1 reference

7 January 2021

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

1 reference

7 January 2021

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

1 reference

7 January 2021

Autoantibody signatures in prostate cancer

1 reference

7 January 2021

Mass spectrometry-based proteomics turns quantitative

1 reference

7 January 2021

Metabolomic identification of novel biomarkers of myocardial ischemia

1 reference

7 January 2021

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

1 reference

7 January 2021

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.

1 reference

7 January 2021

The differential effects of mutant p53 alleles on advanced murine lung cancer

1 reference

7 January 2021

Carcinogenesis in mouse and human cells: parallels and paradoxes

1 reference

7 January 2021

Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development

1 reference

7 January 2021

Unraveling human cancer in the mouse: recent refinements to modeling and analysis

1 reference

7 January 2021

Mass spectrometry-based proteomics

1 reference

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

7 January 2021

Clinical proteomics: translating benchside promise into bedside reality

1 reference

7 January 2021

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry

1 reference

7 January 2021

Integrating 'top-down" and "bottom-up" mass spectrometric approaches for proteomic analysis of Shewanella oneidensis

1 reference

7 January 2021

Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry

1 reference

7 January 2021

Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome

1 reference

7 January 2021

High-Efficiency On-Line Solid-Phase Extraction Coupling to 15−150-μm-i.d. Column Liquid Chromatography for Proteomic Analysis

1 reference

7 January 2021

Characterization of the low molecular weight human serum proteome

1 reference

7 January 2021

Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards

1 reference

7 January 2021

Place of pattern in proteomic biomarker discovery

1 reference

7 January 2021

MapQuant: open-source software for large-scale protein quantification

1 reference

7 January 2021

Advances in proteomics data analysis and display using an accurate mass and time tag approach.

1 reference

7 January 2021

Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching.

1 reference

7 January 2021

De novo sequencing, peptide composition analysis, and composition-based sequencing: a new strategy employing accurate mass determination by fourier transform ion cyclotron resonance mass spectrometry

1 reference

7 January 2021

Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation

1 reference

7 January 2021

Protein identification by mass spectrometry: issues to be considered

1 reference

7 January 2021

The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data

1 reference

7 January 2021

Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS.

1 reference

7 January 2021

Statistical models for protein validation using tandem mass spectral data and protein amino acid sequence databases

1 reference

7 January 2021

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study

1 reference

7 January 2021

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

1 reference

7 January 2021

Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry

1 reference

7 January 2021

Informatics for protein identification by mass spectrometry

1 reference

7 January 2021

Large-scale database searching using tandem mass spectra: looking up the answer in the back of the book

1 reference

7 January 2021

LC/MS applications in drug development

1 reference

7 January 2021

Structural elucidation of drug metabolites by triple-quadrupole mass spectrometry

1 reference

7 January 2021

Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system

1 reference

7 January 2021

Quantitative liquid chromatographic-tandem mass spectrometric determination of orlistat in plasma with a quadrupole ion trap

1 reference

7 January 2021

Peptide quantification by tandem mass spectrometry.

1 reference

7 January 2021

Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases

1 reference

7 January 2021

Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue

1 reference

7 January 2021

Measurement of enkephalin peptides in canine brain regions, teeth, and cerebrospinal fluid with high-performance liquid chromatography and mass spectrometry

1 reference

7 January 2021

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

1 reference

7 January 2021

Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards

1 reference

7 January 2021

Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system

1 reference

7 January 2021

Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry

1 reference

7 January 2021

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins

1 reference

7 January 2021

Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).

1 reference

7 January 2021

Proteomics: from basic research to diagnostic application. A review of requirements & needs

1 reference

7 January 2021

Commutability of the CRM 470 C-reactive protein value in the Dade Behring N High Sensitivity CRP assay.

1 reference

7 January 2021

Standardization activities for harmonization of test results.

1 reference

7 January 2021

Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.

1 reference

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

7 January 2021

European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials

1 reference

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

7 January 2021

Nocturnal plasma levels of cytokines in healthy men.

1 reference

7 January 2021

Effect of Posture on Serum Lipids

1 reference

7 January 2021

Reevaluation of serum-plasma differences in total cholesterol concentration.

1 reference

7 January 2021

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

1 reference

7 January 2021

Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment

1 reference

7 January 2021

Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation

1 reference

7 January 2021

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

1 reference

7 January 2021

[Validation of the Düsseldorfer screening tool: a trait-based approach to assess psychological distress of cancer patients]

1 reference

7 January 2021

ROC curves in clinical chemistry: uses, misuses, and possible solutions

1 reference

7 January 2021

The architecture of diagnostic research

1 reference

7 January 2021

Diagnostics and biomarker development: priming the pipeline

1 reference

7 January 2021

The New European Directive on in vitro Diagnostics

1 reference

7 January 2021

Identifiers

DOI

10.1038/NBT1235

1 reference

14 August 2017

1 reference